ACR® provided input Aug. 7, to the Agency for Healthcare Research and Quality (AHRQ) about the agency’s draft systematic review of the performance of fusion procedures for degenerative disease of the lumbar spine. The comment period ended Aug. 7.
AHRQ’s review evaluates the effectiveness and risks of lumbar fusion for degenerative lumbar spondylolisthesis and nonsurgical treatments for chronic low back pain. Given the relevance to interventional radiologists, ACR addressed key concerns with the agency’s draft review, including:
The ACR Contractor Advisory Committee Network continues to monitor evidence reviews with national and local coverage implications. Member engagement remains vital to ensuring access to essential care. The AHRQ final report will be shared with members once released.
For questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
2027 Medicare Advantage Final Rule, Rate Released
CMS finalized the 2027 Medicare Advantage and Part D rule, updating benefits, cost sharing, Star Ratings policies, and payment rates for plans.
Read morePhysician Groups Warn Visa Delays Could Impact Patient Care
More than 30 medical organizations, including the ACR®️, urged federal officials to address immigration barriers preventing international medical graduates (IMGs) from lawfully entering or remaining in the U.S.
Read moreACR Submits Testimony to Congress
ACR®️ submitted testimony to the U.S. House Committee on Appropriations Labor urging strong federal funding for medical research in federal fiscal year 2027.
Read more